A woman with an extremely premature newborn

JAMA

Volumn 286, Issue 12, 2001, Pages 1498-1505

  Richardson, Douglas K ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIRTH WEIGHT; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FERTILIZATION IN VITRO; GESTATIONAL AGE; HUMAN; NEWBORN; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; SPONTANEOUS ABORTION;

EID: 0035955041     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.12.1498     Document Type: Article

References (94)

1. From how small is too small to how much is too much? ethical issues at the limits of neonatal viability
2. Annual summary of vital statistics - 1998
3. Women at risk for postpartum-onset major depression
4. Ethical issues surrounding multifetal pregnancy reduction and selective termination
5. Survival of the extremely preterm infant in North America in the 1990s
6. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996
7. The EPICure Study: Outcomes to discharge from hospital for infants born at the threshold of viability
8. Variations in practice and outcomes in the Canadian NICU network: 1996-1997
9. Neurologic and developmental disability after extremely preterm birth
10. Neuropsychological and functional outcomes of very low birth weight infants
11. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994
12. Improved outcome into the 1990s for infants weighing 500-999 g at birth
13. Survival and developmental disability in infants with birth weights of 501 to 800 grams, born between 1979 and 1994
14. Changes in survival patterns of very low-birth-weight infants from 1980 to 1993
15. Outcome of infants weighing less than 800 grams at birth: 15 years' experience
16. Developmental outcome in very low birthweight infants: Current status and future trends
17. Has the prevalence of handicapped infants increased with improved survival of the very low birth weight infant?
18. Long-term follow-up of infants discharged from neonatal intensive care units
19. Variability in 28-day outcomes for very low birth weight infants
20. The health and developmental status of very low-birth-weight children at school age
21. The effects of corticosteroid administration before preterm delivery
22. Randomized trial of permissive hypercapnia in preterm infants
23. The Provo Multicenter Early High-frequency Oscillatory Ventilation Trial
24. Early-onset sepsis in very low birth weight neonates
25. Effects of indomethacin in premature infants with patent ductus arteriosus
26. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus
27. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth
28. Mechanisms of perinatal brain injury
29. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants
30. Abnormal pulmonary outcomes in premature infants
31. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease?
32. Mechanisms initiating lung injury in the preterm
33. Feeding strategies for premature infants
34. Longitudinal growth of hospitalized very low birth weight infants
35. Epidemiology of necrotizing enterocolitis
36. Necrotizing enterocolitis: The search for a unifying pathogenic theory leading to prevention
37. Late-onset sepsis in very low birth weight neonates
38. Occurrence of nosocomial bloodstream infections in six neonatal intensive care units
39. White matter injury in the preterm infant
40. Cerebral palsies
41. White matter disorders of prematurity
42. Retinopathy of prematurity
43. Current incidence of retinopathy of prematurity, 1989-1997
44. Multicenter trial of cryotherapy for retinopathy of prematurity
45. Apnea frequently persists beyond term gestation in infants delivered at 24 to 28 weeks
46. Postconceptional age of surviving preterm low-birth-weight infants at hospital discharge
47. Rehospitalization in the first year of life for high-risk survivors
48. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
49. Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants
50. Early educational intervention for very low birth weight infants
51. Enhancing the outcomes of low-birth-weight, premature infants
52. Results at age 8 years of early intervention for low-birth-weight premature infants
53. Measuring the cost of neonatal and perinatal care
54. Economic evaluation of neonatal intensive care of very low-birth-weight infants
55. Five-hundred life-saving interventions and their cost-effectiveness
56. Baby Doe blinders
57. American Academy of Pediatrics Infant Bioethics Task Force and Consultants: Guidelines for infant bioethics committees
58. Perinatal care at the threshold of viability
59. The principles for family-centered neonatal care
60. Overtreatment of neonates?
61. Neonatal viability in the 1990s
62. Prolonging life and allowing death: Infants
63. Delivery room resuscitation decisions for extremely premature infants
64. Early-onset intraventricular hemorrhage in preterm neonates
65. Facing tragic decisions with parents in the neonatal intensive care unit
66. Unilateral do-not-resuscitate order in the neonatal intensive care unit
67. The high-risk infant environment, part 1: The role of the neonatal intensive care unit in the outcome of high-risk infants
68. Baby CareLink: Using the Internet and telemedicine to improve care for high-risk infants
69. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease
70. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g
71. Pulmonary surfactant therapy
72. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome
73. Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase
74. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis
75. Collaborative quality improvement for neonatal intensive care
76. Access to neonatal intensive care
77. Prevention of premature birth
78. The control of labor
79. Intrauterine infection and preterm delivery
80. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants
81. Effect of corticosteroids for fetal maturation on perinatal outcomes
82. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs
83. Multiple courses of antenatal corticosteroids and outcome of premature neonates
84. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?
85. Maternal receipt of magnesium sulfate does not seem to reduce the risk of neonatal white matter damage